Clinical Trial Update: Randomized Controlled Double Blind Trial of Short vs Long Acting Dihydrocodeine in Chronic Non-malignant Pain [Phase 4]

View source ↗

Summary

A Phase 4 randomized, double-blind trial compared short-acting versus long-acting dihydrocodeine for chronic non-malignant pain; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Dihydrocodeine (dihydrocodeine)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Pain | Phase 4 | Status: COMPLETED